channelnewsasia.com - AstraZeneca to axe 1,400 jobs in Europe, shuts three plants
   
 
  blogs  
 
yournews
   
   
 
Video Finance Lifestyle Travel Weather Discussion TV Shows
CNA Live    | About Us 
 
  Home ›
 
Business News

 
 

AstraZeneca to axe 1,400 jobs in Europe, shuts three plants
Posted: 21 November 2008 0102 hrs

 
 
Photos  of

   
 

LONDON: Anglo-Swedish pharmaceuticals giant AstraZeneca said on Thursday it would slash 1,400 jobs by 2013 as it shuts factories in Belgium, Spain and Sweden.

"AstraZeneca will exit three sites, in Porrino in Spain, Destelbergen in Belgium and Umea in Sweden," the company said in an official statement outlining the restructuring.

Jobs will also be affected at facilities in Macclesfield, northwestern England, and Sodertalje in southeastern Sweden.

"These moves will result in a net reduction across the business of 1400 positions by 2013, subject to local consultation," the firm said.

At the same time, the group will invest more cash in its Wuxi plant in China to support continuing growth in the Asia Pacific region.

AstraZeneca executive vice president David Smith said in the statement: "These moves are a continuation of AstraZeneca's programme to improve the organisation's productivity and efficiency.

"I realise these changes are difficult for our affected employees, with whom we will be consulting in the coming months. We believe these changes are necessary for the long-term strength of the business," Smith added. - AFP/de

 

 



Other business News
China hopes US keeps budget deficit to 'appropriate size'
APEC officials discuss ways to make economic growth more inclusive
India PM invites world to invest in economy under reform
China to give Africa US$10 billion in loans
Australia Treasurer says stimulus needed for nation's recovery
Taiwan, China expected to sign financial agreement
'Made in China' now made in Egypt
British Airways cabin crew to vote on strike
Yemen joins gas exporters' club
Cyprus opens new airport to attract tourism, trade
IMF says stimulus needed to aid nascent recovery

 

 
Affiliate Sites:
 
About Us  |  Contact Us  |  Advertise with Us  |  Terms & Conditions